Informatie:
Fout:
ID
16302
Beschrijving
Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193206
Link
https://clinicaltrials.gov/show/NCT00193206
Trefwoorden
Versies (1)
- 10-07-16 10-07-16 -
Geüploaded op
10 juli 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00193206
Eligibility Breast Cancer NCT00193206
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00193206
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Inclusion Criteria
Item
to be included in this study, you must meet the following criteria:
boolean
C1512693 (UMLS CUI [1])
locally advanced/inflammatory adenocarcinoma of the breast
Item
locally advanced/inflammatory adenocarcinoma of the breast
boolean
C0858252 (UMLS CUI [1,1])
C0278601 (UMLS CUI [1,2])
C0677984 (UMLS CUI [1,3])
C0278601 (UMLS CUI [1,2])
C0677984 (UMLS CUI [1,3])
age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
heart function
Item
normal heart function
boolean
C0232164 (UMLS CUI [1])
Ability to perform activities of daily living
Item
able to perform activities of daily living with minimal assistance
boolean
C1518965 (UMLS CUI [1])
prior chemotherapy for breast cancer
Item
no prior chemotherapy for breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
C0005953 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
cardiovascular abnormalities
Item
no evidence or history of significant cardiovascular abnormalities
boolean
C0243050 (UMLS CUI [1])
sentinel node or axillary dissection
Item
sentinel node or axillary dissection
boolean
C2733271 (UMLS CUI [1,1])
C0193867 (UMLS CUI [1,2])
C0193867 (UMLS CUI [1,2])
informed consent
Item
sign an informed consent form
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria
Item
you cannot participate in this study if any of the following apply to you:
boolean
C0680251 (UMLS CUI [1])
pregnant or breast feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
heart disease with congestive heart failure
Item
history of heart disease with congestive heart failure
boolean
C0018802 (UMLS CUI [1])
Myocardial Infarction
Item
heart attack within the previous 6 months
boolean
C0027051 (UMLS CUI [1])
prior chemotherapy or hormone therapy for breast cancer
Item
prior chemotherapy or hormone therapy for breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C1514460 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C1514460 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
active uncontrolled infection
Item
history of active uncontrolled infection
boolean
C0009450 (UMLS CUI [1])
Additional Criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1516637 (UMLS CUI [1])